Dr. Ravichandran is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8333 Naab Rd Ste 400
Indianapolis, IN 46260Phone+1 317-338-6666Fax+1 317-338-6066
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Cardiovascular Disease, 2009 - 2013
- University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 2006 - 2009
- University of Minnesota Medical SchoolClass of 2006
Certifications & Licensure
- IN State Medical License 2013 - 2025
- IL State Medical License 2006 - 2014
- MO State Medical License 2011 - 2014
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
Clinical Trials
- Lavare Cycle in Patients Receiving HeartWare Left Ventricular Assist Device Start of enrollment: 2020 Aug 10
Publications & Presentations
PubMed
- 251 citationsInhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung DiseaseAaron B. Waxman, Ricardo Restrepo-Jaramillo, Thenappan Thenappan, Ashwin Ravichandran, Peter A. Engel
The New England Journal of Medicine. 2021-01-28 - 24 citationsLong-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study.Aaron Waxman, Ricardo Restrepo-Jaramillo, Thenappan Thenappan, Peter Engel, Abubakr Bajwa
The European Respiratory Journal. 2023-06-01 - 99 citationsOutcomes with the Tandem Protek Duo Dual-Lumen Percutaneous Right Ventricular Assist Device.Ashwin Ravichandran, David A. Baran, Kelly Stelling, Jennifer A Cowger, Christopher T. Salerno
ASAIO Journal. 2017-10-01
Press Mentions
- Current Key Questions on COVID-19 and Cardiovascular DiseaseMarch 2nd, 2021
- Indy Doctor Helping to Bring First-of-Its-Kind Treatment for Lung Disease That Could Help COVID-19 PatientsFebruary 9th, 2021
- Aria CV Implants First Patient with Pulmonary Hypertension SystemFebruary 28th, 2024
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: